| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872716 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 4 Pages |
Abstract
Concomitant chemoradiotherapy for refractory or chemoresistant-relapsed lymphoma induced high hematologic toxicity, but seemed adequate for controlling local bulky tumor masses. No toxicity-related death was observed.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Theodore M.D., Simona M.D., Vincent M.D., Serge Ph.D., Christophe M.D., Patrice M.D.,